... San Antonio Breast Cancer Symposium (SABCS) in December Strong cash ... Biotechnology: Pharmaceutical Preparations. Health Care. Medical/Nursing ...
News
- Director Harmon Cyrus was granted 29,250 shares and sold $147,956 worth of ... - Quantisnow
- Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in ...
Gonzalez Convention Center in San Antonio, Texas. . The poster presents ... Celcuity is a clinical-stage biotechnology company focused on ...
- LYNPARZA® (olaparib) demonstrated clinically meaningful prolonged survival benefit ... - BioSpace
These results were presented today at the San Antonio Breast Cancer ... Sarepta, Biotech's Regulatory Go-Getter, Signs Standout Rare Disease Deal.
- Breast cancer researcher receives outstanding investigator award - Healio
SAN ANTONIO — Christina Curtis, PhD, MSc, received this year's AACR ... The work can be conducted in any biomedical research discipline, including ...
- Io Therapeutics, Inc., announces presentation of data from studies of its RAR gamma agonist ...
... San Antonio Breast Cancer Symposium 2024, currently underway in San Antonio, Texas. ... Editorial · Sarepta, Biotech's Regulatory Go-Getter, Signs ...